[Featured Stock] iCure Rises 12% Ahead of Launching Patch-Type Dementia Treatment
![[Featured Stock] iCure Rises 12% Ahead of Launching Patch-Type Dementia Treatment](http://www.asiae.co.kr/news/img_view.htm?img=2022070109160433907_1656634565.jpg)
[Asia Economy Reporter Minji Lee] IQure is showing an upward trend following news that it will launch the dementia treatment drug Donepezil patch next month.
At 9:14 a.m. on the 1st, IQure was trading at 11,850 won, up 10.23% from the previous trading day. On the same day, IQure surged to 12,350 won during intraday trading.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
IQure developed the world's first Donepezil patch. It is expected that sales will increase significantly due to reduced side effects compared to Donepezil pills and ease of use. According to the industry, the domestic Donepezil market size reaches 230 billion won.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
